CAS: 1062169-56-5 - WYE-354
Formula:C24H29N7O5
InChI:InChI=1S/C24H29N7O5/c1-34-23(32)26-17-5-3-16(4-6-17)20-27-21(29-11-13-36-14-12-29)19-15-25-31(22(19)28-20)18-7-9-30(10-8-18)24(33)35-2/h3-6,15,18H,7-14H2,1-2H3,(H,26,32)
- Synonyms:
- 4-[6-[4-[(Methoxycarbonyl)amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylic acid methyl ester
- Methyl 4-[6-{4-[(methoxycarbonyl)amino]phenyl}-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylate
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | WYE-354 REF: IN-DA008SSTCAS: 1062169-56-5 | 98% | 151.00 €~619.00 € | Mon 02 Dec 24 |
 | WYE-354 REF: TM-T6731CAS: 1062169-56-5 | 98.31% - 99.61% | 50.00 €~356.00 € | Tue 10 Dec 24 |
 | WYE 354 REF: TR-W950000CAS: 1062169-56-5 | - - - | 15,221.00 € | Fri 10 Jan 25 |
 | mTOR Kinase Inhibitor II, WYE-354 REF: 3D-MSB16956CAS: 1062169-56-5 | Min. 95% | To inquire | Mon 13 Jan 25 |
Ref: IN-DA008SST
| 25mg | 171.00 € | ||
| 50mg | 206.00 € | ||
| 100mg | 463.00 € | ||
| 250mg | 619.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
WYE-354
CAS:1062169-56-5
WYE-354 is a selective mTOR inhibitor (IC50=5 nM), targeting mTORC1/C2 over PI3Kα (>100x) and …
Formula:
C24H29N7O5
Purity:
98.31% - 99.61%
Color and Shape:
Solid
Molecular weight:
495.53
Ref: TM-T6731
| 5mg | 50.00 € | ||
| 10mg | 83.00 € | ||
| 25mg | 152.00 € | ||
| 50mg | 275.00 € | ||
| 100mg | 356.00 € | ||
| 1mL*10mM (DMSO) | 52.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
WYE 354
Controlled ProductCAS:1062169-56-5
Formula:
C24H29N7O5
Color and Shape:
Neat
Molecular weight:
495.531
Ref: TR-W950000
| 500mg | 15,221.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
mTOR Kinase Inhibitor II, WYE-354
CAS:1062169-56-5
WYE-354 is a pyrimidine compound that inhibits mTOR kinase, the target of rapamycin. It has …
Formula:
C24H29N7O5
Purity:
Min. 95%
Molecular weight:
495.53 g/mol
Ref: 3D-MSB16956
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
